Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid in supratentorial brain tumor resection surgery
PACTR202204547358213Phase 2Recruiting
- Sponsor
- Mansoura University
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in brain neoplasm comparing Group T tranexamic acid group with Group C placebo group (2 arms). Primary endpoint: jugular venous oxygen saturation. Started May 2022; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
brain neoplasm
Beyond the preview
Go deeper on PACTR202204547358213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202204547358213.